Takeda closes $62B purchase of Shire, creating largest Mass. biotech employer

//Takeda closes $62B purchase of Shire, creating largest Mass. biotech employer

Takeda closes $62B purchase of Shire, creating largest Mass. biotech employer

Takeda Pharmaceutical Co. Ltd. and Shire plc finalized their record-setting tie-up Monday, creating what will likely be Massachusetts' largest life science employer and one of the world's largest drug companies. The Japanese drugmaker announced late Monday that it had completed the acquisition of Shire, which is based in Ireland but has its largest hub of operations in Massachusetts. Shire will stop trading on the Nasdaq exchange on Wednesday. Takeda said that Shire CEO Flemming Ornskov and CFO…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-01-08T01:46:47+00:00 January 8th, 2019|Healthcare|

About the Author: